Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wael E. Houssen is active.

Publication


Featured researches published by Wael E. Houssen.


Nature Structural & Molecular Biology | 2012

The mechanism of patellamide macrocyclization revealed by the characterization of the PatG macrocyclase domain

Jesko Koehnke; Andrew F. Bent; Wael E. Houssen; David Zollman; Falk Morawitz; Sally L. Shirran; Jeremie Vendome; Ada Nneoyi-Egbe; Laurent Trembleau; Catherine H. Botting; Margaret C. M. Smith; Marcel Jaspars; James H. Naismith

Peptide macrocycles are found in many biologically active natural products. Their versatility, resistance to proteolysis and ability to traverse membranes has made them desirable molecules. Although technologies exist to synthesize such compounds, the full extent of diversity found among natural macrocycles has yet to be achieved synthetically. Cyanobactins are ribosomal peptide macrocycles encompassing an extraordinarily diverse range of ring sizes, amino acids and chemical modifications. We report the structure, biochemical characterization and initial engineering of the PatG macrocyclase domain of Prochloron sp. from the patellamide pathway that catalyzes the macrocyclization of linear peptides. The enzyme contains insertions in the subtilisin fold to allow it to recognize a three-residue signature, bind substrate in a preorganized and unusual conformation, shield an acyl-enzyme intermediate from water and catalyze peptide bond formation. The ability to macrocyclize a broad range of nonactivated substrates has wide biotechnology applications.


Journal of Natural Products | 2011

Diverse Metabolic Profiles of a Streptomyces Strain Isolated from a Hyper-arid Environment

Mostafa E. Rateb; Wael E. Houssen; William T. A. Harrison; Hai Deng; Chinyere K. Okoro; Juan A. Asenjo; Barbara A. Andrews; Alan T. Bull; Michael Goodfellow; Rainer Ebel; Marcel Jaspars

The metabolic profile of Streptomyces sp. strain C34, isolated from the Chilean hyper-arid Atacama Desert soil, is dependent on the culture media used for its growth. The application of an OSMAC approach on this strain using a range of cultivation media resulted in the isolation and identification of three new compounds from the rare class of 22-membered macrolactone polyketides, named chaxalactins A-C (1-3). In addition, the known compounds deferroxamine E (4), hygromycin A (5), and 5″-dihydrohygromycin A (6) were detected. The isolated compounds were characterized by NMR spectroscopy and accurate mass spectrometric analysis. Compounds 1-3 displayed strong activity against Gram-positive but weak activity Gram-negative strains tested.


Journal of Natural Products | 2011

Chaxamycins A–D, Bioactive Ansamycins from a Hyper-arid Desert Streptomyces sp.

Mostafa E. Rateb; Wael E. Houssen; Markus F. F. Arnold; Mostafa H. Abdelrahman; Hai Deng; William T. A. Harrison; Chinyere K. Okoro; Juan A. Asenjo; Barbara A. Andrews; Gail P. Ferguson; Alan T. Bull; Michael Goodfellow; Rainer Ebel; Marcel Jaspars

Streptomyces sp. strain C34, isolated from soil collected in the Chilean hyper-arid Atacama Desert, was cultured on different media, resulting in the isolation and identification of four new ansamycin-type polyketides. The organism was selected for chemical investigation on the basis of a genome-mining PCR-based experiment targeting the gene encoding rifamycin-specific 3-amino-5-hydroxybenzoic acid synthetase (AHBA). The isolated compounds were structurally characterized using NMR and MS techniques and named chaxamycins A-D (1-4). Compounds 1-4 were tested for their antibacterial activity against Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 25922 and for their ability to inhibit the intrinsic ATPase activity of the heat shock protein 90 (Hsp90). Chaxamycin D (4), which showed a selective antibacterial activity against S. aureus ATCC 25923, was tested further against a panel of MRSA clinical isolates. In a virtual screening experiment, chaxamycins A-D (1-4) have also been docked into the ATP-binding pocket in the N-terminal domain of the Hsp90, and the observed interactions are discussed.


Nature Chemical Biology | 2015

Structural analysis of leader peptide binding enables leader-free cyanobactin processing

Jesko Koehnke; Greg Mann; Andrew F. Bent; Hannes Ludewig; Sally L. Shirran; Catherine H. Botting; Tomas Lebl; Wael E. Houssen; Marcel Jaspars; James H. Naismith

Regioselective modification of amino acids within the context of a peptide is common to a number of biosynthetic pathways and many such products have potential as therapeutics. The ATP dependent enzyme LynD heterocyclizes multiple cysteine residues to thiazolines within a peptide substrate. The enzyme requires the substrate to have conserved N-terminal leader for full activity. Catalysis is almost insensitive to immediately flanking residues in the substrate suggesting recognition occurs distant from the active site. Nucleotide and peptide substrate co-complex structures of LynD reveal the substrate leader peptide binds to and extends the β-sheet of a conserved domain of LynD, whilst catalysis is accomplished in another conserved domain. The spatial segregation of catalysis from recognition combines seemingly contradictory properties of regioselectivity and promiscuity; it appears to be a conserved strategy in other peptide modifying enzymes. A variant of LynD that efficiently processes substrates without a leader peptide has been engineered.


Angewandte Chemie | 2013

The Cyanobactin Heterocyclase Enzyme: A Processive Adenylase That Operates with a Defined Order of Reaction

Jesko Koehnke; Andrew F. Bent; David Zollman; Kieran Smith; Wael E. Houssen; Xiaofeng Zhu; Greg Mann; Tomas Lebl; Richard Scharff; Sally L. Shirran; Catherine H. Botting; Marcel Jaspars; Ulrich Schwarz-Linek; James H. Naismith

This work was funded by the Leverhulme Trust (RPG-2012–504), BBSRC (BB/K015508/1) and the University of St Andrews infrastructure is supported by a Wellcome Trust Capital Award (086036).


RSC Advances | 2013

Induction of diverse secondary metabolites in Aspergillus fumigatus by microbial co-culture

Mostafa E. Rateb; Irene Hallyburton; Wael E. Houssen; Alan T. Bull; Michael Goodfellow; Rakesh Santhanam; Marcel Jaspars; Rainer Ebel

An established culture of Aspergillus fumigatus MBC-F1-10 proved to be very receptive to external stimuli and reacted with the production of secondary metabolites which were undetectable when the fungus was grown under standard conditions. Firstly, co-cultivation with the type strain of Streptomyces bullii, an isolate from hyper-arid Atacama desert soil, led to the isolation of ergosterol 1, seven metabolites belonging to the diketopiperazine alkaloids; brevianamide F 2, spirotryprostatin A 3, 6-methoxy spirotryprostatin B 4, fumitremorgin C and its 12,13-dihydroxy derivative (5–6), fumitremorgin B 7, and verruculogen 8, in addition to 11-O-methylpseurotin A 9 and its new isomer 11-O-methylpseurotin A210. In an independent experiment, addition of N-butyryl-DL-homoserine lactone to the culture medium led to the production of emestrins A and B (11–12). Neither microbe produced these compounds when cultured alone. The structures of all compounds were elucidated using NMR spectroscopic techniques and mass spectrometric analysis. The isolated compounds were tested for their potential antibacterial and antiprotozoal activities.


ChemBioChem | 2010

Azole-Based Cyclic Peptides from the Sea Squirt Lissoclinum Patella: Old Scaffolds, New Avenues

Wael E. Houssen; Marcel Jaspars

wide variety of bioactive oxazoline-, thiazoleand thiazolinecontaining cyclic hexa-, heptaand octa-peptides (Scheme 1). The biological activities of many of these compounds can be partially attributed to the conformational constraints imposed by the heterocycles and could be related to their ability to chelate metal ions. L. patella harbours an obligate symbiont, Prochloron sp. , which has recently been proved to be the true producer of these metabolites through the elegant post-translationally modified ribosomal pathway. 3] The deciphering of the genetic code of this biosynthetic pathway has spurred a great interest in using this machinery to heterologously express these metabolites as well as unnatural related ones in a combinatorial fashion. 5] It also encouraged many perceptive biochemists to search for similar pathways in the genomes of other organisms. It is now clear that ribosomal peptide biosynthetic pathways are universal and share common themes with the widely known nonribosomal systems. However, many intriguing questions still remain for several of the biosynthetic steps to these compounds. In this minireview, we aim to compile the literature on the peptides previously isolated from L. patella and highlight the different features that make these compounds chemically, biologically and biosynthetically interesting. We also intend to discuss the ribosomal biosynthesis of these compounds and the recent efforts to manipulate this system for the discovery of new bioactive homologues to the currently known azole-based peptides.


Angewandte Chemie | 2014

An Efficient Method for the In Vitro Production of Azol(in)e-Based Cyclic Peptides

Wael E. Houssen; Andrew F. Bent; Andrew R. McEwan; Nathalie Pieiller; Jioji N. Tabudravu; Jesko Koehnke; Greg Mann; Rosemary I. Adaba; Louise Thomas; Usama W. Hawas; Huanting Liu; Ulrich Schwarz-Linek; Margaret C. M. Smith; James H. Naismith; Marcel Jaspars

Heterocycle-containing cyclic peptides are promising scaffolds for the pharmaceutical industry but their chemical synthesis is very challenging. A new universal method has been devised to prepare these compounds by using a set of engineered marine-derived enzymes and substrates obtained from a family of ribosomally produced and post-translationally modified peptides called the cyanobactins. The substrate precursor peptide is engineered to have a non-native protease cleavage site that can be rapidly cleaved. The other enzymes used are heterocyclases that convert Cys or Cys/Ser/Thr into their corresponding azolines. A macrocycle is formed using a macrocyclase enzyme, followed by oxidation of the azolines to azoles with a specific oxidase. The work is exemplified by the production of 17 macrocycles containing 6–9 residues representing 11 out of the 20 canonical amino acids.


ChemBioChem | 2012

The discovery of new cyanobactins from Cyanothece PCC 7425 defines a new signature for processing of patellamides.

Wael E. Houssen; Jesko Koehnke; David Zollman; Jeremie Vendome; Andrea Raab; Margaret C. M. Smith; James H. Naismith; Marcel Jaspars

Cyanobactins, including patellamides, are a group of cyanobacterial post‐translationally modified ribosomal cyclic peptides. The final product should in theory be predictable from the sequence of the precursor peptide and the associated tailoring enzymes. Understanding the mechanism and recognition requirements of these enzymes will allow their rational engineering. We have identified three new cyanobactins from a Cyanothece PCC 7425 culture subjected to a heat shock. One of these compounds revealed a novel signature signal for ThcA, the subtilisin‐like serine protease that is homologous to the patellamide protease PatA. The crystal structure of the latter and modelling studies allow rationalisation of the recognition determinants for both enzymes, consistent with the ribosomal biosynthetic origin of the new compounds.


ChemBioChem | 2010

Solution structure of the leader sequence of the patellamide precursor peptide, PatE1-34.

Wael E. Houssen; Stephen H. Wright; Arnout P. Kalverda; Gary S. Thompson; Sharon M. Kelly; Marcel Jaspars

The solution structure of the leader sequence of the patellamide precursor peptide was analysed by using CD and determined with NOE‐restrained molecular dynamics calculations. This leader sequence is highly conserved in the precursor peptides of some other cyanobactins harbouring heterocycles, and is assumed to play a role in targeting the precursor peptide to the post‐translational machinery. The sequence was observed to form an α‐helix spanning residues 13–28 with a hydrophobic surface on one side of the helix. This hydrophobic surface is proposed to be the site of the initial binding with modifying enzymes.

Collaboration


Dive into the Wael E. Houssen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rainer Ebel

University of Aberdeen

View shared research outputs
Top Co-Authors

Avatar

Andrew F. Bent

University of St Andrews

View shared research outputs
Top Co-Authors

Avatar

Jesko Koehnke

University of St Andrews

View shared research outputs
Top Co-Authors

Avatar

Eva Alonso

University of Santiago de Compostela

View shared research outputs
Top Co-Authors

Avatar

Luis M. Botana

University of Santiago de Compostela

View shared research outputs
Top Co-Authors

Avatar

Greg Mann

University of St Andrews

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amparo Alfonso

University of Santiago de Compostela

View shared research outputs
Researchain Logo
Decentralizing Knowledge